Screener
aTyr Pharma ATYR Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by aTyr Pharma in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The source filing: aTyr Pharma’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001339970-26-000053
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts payable | $3,242 | $3,891 |
| Accrued expenses | 6,690 | 9,791 |
| Current portion of operating lease liability | 946 | 836 |
| Current portion of financing lease liability | 518 | 630 |
| Total current liabilities | 11,396 | 15,148 |
| Long-term operating lease liability, net of current portion | 9,799 | 10,308 |
| Long-term financing lease liability, net of current portion | 36 | 259 |
| Commitments and contingencies (Note 4) |
Item 1. Financial Statements
FAQ
- What is aTyr Pharma's current debt?
- aTyr Pharma (ATYR) reported current debt of $518K in Q2 2026.
- How has aTyr Pharma's current debt changed year-over-year?
- aTyr Pharma's current debt decreased by 7.8% year-over-year, from $562K to $518K.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about aTyr Pharma's current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude